Frailty and SARS-CoV-2 infection. A population-based study in a highly endemic village.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Prevalence and association of frailty with SARS-CoV-2 infection in older adults in Southern Switzerland-Findings from the Corona Immunitas Ticino Study.BMC geriatrics · 2023
   Article
2. Frailty but not sarcopenia nor malnutrition increases the risk of developing COVID-19 in older community-dwelling adults.Aging clinical and experimental research · 2022
   Article
3. Hand grip strength before and after SARS-CoV-2 infection in community-dwelling older adults.Journal of the American Geriatrics Society · 2021
   Article
4. Different aspects of frailty and COVID-19: points to consider in the current pandemic and future ones.BMC geriatrics · 2021
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as